Oscotec Inc. (KOSDAQ:039200)
South Korea
· Delayed Price · Currency is KRW 50,500
-900 (-1.75%)
Mar 9, 2026, 3:30 PM KST
Oscotec Revenue
Oscotec had revenue of 8.95B KRW in the quarter ending September 30, 2025, a decrease of -69.21%. This brings the company's revenue in the last twelve months to 23.23B, down -27.34% year-over-year. In the year 2024, Oscotec had annual revenue of 34.01B with 586.89% growth.
Revenue (ttm)
23.23B
Revenue Growth
-27.34%
P/S Ratio
83.15
Revenue / Employee
438.39M
Employees
53
Market Cap
1,932.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.01B | 29.06B | 586.89% |
| Dec 31, 2023 | 4.95B | -111.45M | -2.20% |
| Dec 31, 2022 | 5.06B | 1.16B | 29.71% |
| Dec 31, 2021 | 3.90B | -39.57B | -91.02% |
| Dec 31, 2020 | 43.47B | 39.10B | 895.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,556.97B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| Sam Chun Dang Pharm. | 220.74B |
| Orum Therapeutics | 25.48M |
| L&C BIO Co.,LTD | 79.99B |
| Daewoong Pharmaceutical | 1,541.65B |
| Chabiotech | 1,197.69B |